Global pharmaceutical company GlaxoSmithKline PLC (GSK) has several attractive franchises and pipeline drug candidates that have the potential to add significant value.
From Diamond Hill Capital's Select Fund Commentary – First Quarter 2014.
Global pharmaceutical company GlaxoSmithKline PLC (GSK) has several attractive franchises and pipeline drug candidates that have the potential to add significant value.
From Diamond Hill Capital's Select Fund Commentary – First Quarter 2014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey